NL-OMON51462招募中2 期
Alkaline Phosphatase as treatment of Ischemia Reperfusion Injury to prevent delayed graft function in deceased donor kidney transplantation - APhIRI II
efrologie0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- Age > 18
- •- Recipients of a donor awaiting cardiac death on the intensive care
- •(definition of a donor cardiac death type III according to the *Maastricht
- •classification*)
- •- Written informed consent
排除标准
- •- Strict vegetarians or vegans
- •- History of allergy to bovine proteins
研究者
相似试验
已完成
3 期
Alkaline Phosphatase to prevent ischemia reperfusion injury in living kidney transplantatioNL-OMON50363Vrije Universiteit Medisch Centrum40
进行中（未招募）
1 期
Alkaline Phosphatase to prevent ischemia reperfusion injury in living kidney transplantatioIschemia reperfusion injury in living donor kidney transplantationEUCTR2017-004737-85-NLAmsterdam UMC, location VUmc40
进行中（未招募）
1 期
RESCAP® rescue therapy in COVID19 diseaseCOVID 19MedDRA version: 20.0Level: LLTClassification code 10062357Term: SIRSSystem Organ Class: 100000004867EUCTR2020-001714-38-NLRed Cross Hospital Beverwijk106
尚未招募
不适用
Alkaline phosphatase for reducing systemic inflammatory response syndrome (SIRS) in patients with Sars-CoV-2 infection and acute respiratory insufficiency (COVID 19)COVID-19NL-OMON22695Rode Kruis ziekenhuis Beverwijk124
进行中（未招募）
1 期
RESCAP® rescue therapy in COVID19 diseaseCOVID 19MedDRA version: 20.0Level: LLTClassification code 10062357Term: SIRSSystem Organ Class: 100000004867EUCTR2020-001714-38-BEJessa Hospital44